News

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...
In the 10-Q report, Taysha Gene Therapies disclosed its financial condition, stating that it has funded its operations ...
(Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial ...
BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely ...
Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.
Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...
From decoy DNA sequences to plasmapheresis, researchers are testing strategies to get around anti-AAV antibodies that hinder ...
Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...
Researchers from The University of Osaka found that mass photometry can accurately distinguish full and empty rAAV particles ...
There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.